Effect of DPP4 inhibitor or alpha-glucosidase inhibitor on postprandial lipemia and endothelial dysfunction

Effect of DPP4 inhibitor or alpha-glucosidase inhibitor on postprandial lipemia and endothelial dysfunction - Effect of DPP4 inhibitor or alpha-glucosidase inhibitor on postprandial lipemia and endothelial dysfunction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012738

Enrollment

Registered

2013-12-31

Start date

2013-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

vildagliptin voglibose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers

Exclusion criteria

Exclusion criteria: 1)Diabetes 2)Dyslipidemia 3)Hypertension 4)Chronic inflammatory disease

Design outcomes

Primary

Measure	Time frame
Change in lipid profiles and endothelial dysfunction after cookie test	—

Countries

Japan

Contacts

Public ContactSeiji Nanba

Okayama Rosai Hospital Department of Cardiology

snanba@okayamah.rofuku.go.jp086-262-0131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026